IL78158A - Pharmaceutical compositions containing 3'-azido-3'-deoxythymidine - Google Patents

Pharmaceutical compositions containing 3'-azido-3'-deoxythymidine

Info

Publication number
IL78158A
IL78158A IL78158A IL7815886A IL78158A IL 78158 A IL78158 A IL 78158A IL 78158 A IL78158 A IL 78158A IL 7815886 A IL7815886 A IL 7815886A IL 78158 A IL78158 A IL 78158A
Authority
IL
Israel
Prior art keywords
deoxythymidine
azido
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Application number
IL78158A
Other languages
English (en)
Other versions
IL78158A0 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27516579&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL78158(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB858506869A external-priority patent/GB8506869D0/en
Priority claimed from GB858511774A external-priority patent/GB8511774D0/en
Priority claimed from US06/776,899 external-priority patent/US4724232A/en
Priority claimed from GB858523881A external-priority patent/GB8523881D0/en
Priority claimed from GB868603450A external-priority patent/GB8603450D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Priority to IL85095A priority Critical patent/IL85095A/xx
Publication of IL78158A0 publication Critical patent/IL78158A0/xx
Priority to IL85095A priority patent/IL85095A0/xx
Priority to IL85096A priority patent/IL85096A0/xx
Publication of IL78158A publication Critical patent/IL78158A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL78158A 1985-03-16 1986-03-14 Pharmaceutical compositions containing 3'-azido-3'-deoxythymidine IL78158A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IL85095A IL85095A (en) 1985-05-09 1986-03-14 Pharmaceutical compositions containing 3'-azido-3'-deoxythymidine derivatives,certain such novel compounds and their preparation
IL85095A IL85095A0 (en) 1985-03-16 1988-01-13 Pharmaceutical compositions containing 3'-azido-3'-deoxythymidine derivatives,certain such novel compounds and their preparation
IL85096A IL85096A0 (en) 1985-03-16 1988-01-13 Use of 3'-azido-3'-deoxythymidine in the treatment or prophylaxis of human retrovirus infection

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB858506869A GB8506869D0 (en) 1985-03-16 1985-03-16 Antiviral compound
GB858511774A GB8511774D0 (en) 1985-05-09 1985-05-09 Antiviral compounds
US06/776,899 US4724232A (en) 1985-03-16 1985-09-17 Treatment of human viral infections
GB858523881A GB8523881D0 (en) 1985-09-27 1985-09-27 Antiviral compounds
GB868603450A GB8603450D0 (en) 1986-02-12 1986-02-12 Antiviral compounds

Publications (2)

Publication Number Publication Date
IL78158A0 IL78158A0 (en) 1986-07-31
IL78158A true IL78158A (en) 1988-04-29

Family

ID=27516579

Family Applications (1)

Application Number Title Priority Date Filing Date
IL78158A IL78158A (en) 1985-03-16 1986-03-14 Pharmaceutical compositions containing 3'-azido-3'-deoxythymidine

Country Status (21)

Country Link
EP (2) EP0291633B1 (de)
JP (1) JPH0780898B2 (de)
AP (1) AP11A (de)
AT (4) ATE44464T1 (de)
AU (1) AU572019B2 (de)
CA (1) CA1238277A (de)
CS (1) CS385191A3 (de)
CY (2) CY1508A (de)
DE (4) DE3608606A1 (de)
DK (1) DK164392C (de)
FI (1) FI85978C (de)
GR (1) GR860712B (de)
HK (2) HK85789A (de)
IE (1) IE56503B1 (de)
IL (1) IL78158A (de)
MC (1) MC1742A1 (de)
MY (1) MY102693A (de)
NZ (1) NZ215486A (de)
PH (1) PH24388A (de)
PT (1) PT82199B (de)
SG (1) SG62889G (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650741T2 (de) * 1985-09-17 2000-10-12 The Wellcome Foundation Ltd., Greenford Kombination therapeutische Nukleoside mit weiteren therapeutisch wirksamen Komponenten.
US5084445A (en) * 1986-05-01 1992-01-28 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine
US5077279A (en) * 1986-05-01 1991-12-31 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine anti-viral composition
US4841039A (en) * 1986-05-01 1989-06-20 Emory University 2',3'-dideoxy-5-substituted uridines and related compounds as antiviral agents
US4916122A (en) * 1987-01-28 1990-04-10 University Of Georgia Research Foundation, Inc. 3'-Azido-2',3'-dideoxyuridine anti-retroviral composition
WO1988003804A2 (en) * 1986-11-21 1988-06-02 Max-Planck-Gesellschaft Zur Förderung Der Wissensc Method of treating viral infections in humans and compositions therefor
US4880782A (en) * 1986-11-21 1989-11-14 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften E.V. Method of treating viral infections in humans and compositions therefor
SE8605503D0 (sv) * 1986-12-19 1986-12-19 Astra Laekemedel Ab Novel medicinal use
US5190926A (en) * 1987-01-28 1993-03-02 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxypyrimidines and related compounds as antiviral agents
PL271196A1 (en) * 1987-03-16 1988-12-08 Wellcome Found Method for manufacturing a new i-(3-azide-2,3-didesoxy-d-erythro-pentafuranosil)-5-methyl-ih-pyrimidinon-2
EP0282618A1 (de) * 1987-03-18 1988-09-21 Vereniging Het Nederlands Kanker Instituut 1-Deoxynojirimycin als Anti-HIV-Therapeutikum
EP0286825A3 (de) * 1987-03-18 1989-04-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verwendung von 3'-fluro-3'-deoxythymidine zur Herstellung von medicamenten zur Behandlung von Viruskrankheiten
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases
FI881413A7 (fi) * 1987-03-25 1988-09-26 The Wellcome Foundation Ltd Menetelmä 3'-atsido-3'-deoksitymidiinin valmistamiseksi.
GB8707421D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
US5185437A (en) * 1987-04-09 1993-02-09 Burroughs Wellcome Co. Therapeutic nucleosides
IL86007A0 (en) * 1987-04-09 1988-09-30 Wellcome Found 6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them
IL86009A (en) * 1987-04-10 1991-09-16 Us Health Liposome-encapsulated phosphorylated nucleosides for treatment of retroviral diseases
US5215970A (en) * 1987-04-16 1993-06-01 Medivir Ab Nucleosides and nucleotide analogues, pharmaceutical composition and processes for the preparation of the compounds
SE8701605D0 (sv) * 1987-04-16 1987-04-16 Astra Ab Novel medicinal compounds
ATE72122T1 (de) * 1987-04-24 1992-02-15 Wellcome Found Antivirale mischungen.
US4863927A (en) * 1987-05-11 1989-09-05 Merck & Co., Inc. 1-(2-hydroxymethyl)cycloalkylmethyl)-5-substituted uracils
YU110888A (en) * 1987-06-10 1989-08-31 Wellcome Found Process for obtaining timine derivatives
USRE33887E (en) * 1987-06-22 1992-04-14 Hoffmann-La Roche Inc. Anti-retroviral compounds
SU1548182A1 (ru) * 1987-12-29 1990-03-07 Институт молекулярной биологии АН СССР 5 @ -Фосфонаты 3 @ -азидо-2 @ ,3 @ -дидезоксинуклеозидов, вл ющиес специфическими ингибиторами вируса СПИД в культуре лимфоцитов человека Н9/ШВ
US5384396A (en) * 1988-02-23 1995-01-24 The University Of Georgia Research Foundation, Inc. Process for the deoxygenation of nucleosides
DE3824669C2 (de) * 1988-07-20 1999-05-06 Wondrak Ewald M Verwendung von Trinatrium-Phosphonoformat
US4987224A (en) * 1988-08-02 1991-01-22 University Of Georgia Research Foundation, Inc. Method of preparation of 2',3'-dideoxynucleosides
EP0355245A1 (de) * 1988-08-26 1990-02-28 Michel Vandevelde Anwendung von Inhibitoren der reversen Transcriptase von Retroviren
HU205089B (en) * 1989-05-31 1992-03-30 Biogal Gyogyszergyar Process for producing new thymine derivatives and pharmaceutical compositions comprising same
DE9017987U1 (de) * 1989-11-09 1993-12-09 Asta Medica AG, 60314 Frankfurt Arzneimittel, welche als Wirkstoff Schwefel enthaltende Carbonsäuren enthalten
US5585367A (en) * 1990-04-19 1996-12-17 Previsan S.A. Method of treating humans and animals infected with viruses of the retrovirus group
CA2080820C (fr) * 1990-04-19 2003-11-25 Michel Vandevelde Derives azoiques, compositions pharmaceutiques et desinfectantes les contenant et leurs utilisations
US6812233B1 (en) 1991-03-06 2004-11-02 Emory University Therapeutic nucleosides
GB9104740D0 (en) * 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
US5593993A (en) * 1991-08-02 1997-01-14 Medivir Ab Method for inhibition of HIV related viruses
IL102548A (en) * 1991-08-02 1998-08-16 Medivir Ab Thiourea derivatives for use in the preparation of medicaments for the inhibition of hiv and the treatment of aids and some such novel compounds
AU4079593A (en) * 1992-05-13 1993-12-13 Wellcome Foundation Limited, The Therapeutic combinations
US6177435B1 (en) 1992-05-13 2001-01-23 Glaxo Wellcome Inc. Therapeutic combinations
GR920100326A (el) * 1992-07-21 1994-03-31 Medivir Ag Ενώσεις και μέ?οδοι αναστολής του HIV και των σχετικών ιών.
DE4336640A1 (de) * 1993-10-22 1995-04-27 Deutsches Rheuma Forschungszen Neue Metallchelate, Verfahren zu deren Herstellung sowie deren Verwendung als antivirale Arzneimittel
CA2270600A1 (en) 1999-05-03 2000-11-03 Infectio Recherche Inc. Method and formulations for the treatment of diseases, particularly those caused by human immunodeficiency virus and leishmania
CN102229605B (zh) 2001-10-26 2015-01-14 Msd意大利有限公司 关于hiv整合酶的n-取代的羟基嘧啶酮甲酰胺抑制剂
EP2316469A1 (de) 2002-02-22 2011-05-04 Shire LLC Abgabesystem und Verfahren zum Schutz und zur Verabreichung von Dextroamphetamin
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (de) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Verwendung von PDE III Ihibitoren zur Reduktion der Herzgrösse in an Herzversagen leidenden Säugern
SI3865120T1 (sl) 2013-07-19 2025-12-31 Boehringer Ingelheim Vetmedica Gmbh Konzervirani eterificirani derivati ciklodekstrina, ki vsebujejo tekoč vodni farmacevtski sestavek
WO2022008025A1 (en) * 2020-07-05 2022-01-13 Since & Technology Development Fund Authority 2-hydroxyiminopyrimidine nucleosides and derivitives and antiviral uses thereto

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE73219B1 (en) * 1985-03-16 1997-05-07 Wellcome Found Therapeutic nucleosides

Also Published As

Publication number Publication date
HK164395A (en) 1995-10-27
EP0196185A2 (de) 1986-10-01
FI861069L (fi) 1986-09-17
MC1742A1 (fr) 1987-02-26
DE3687069D1 (de) 1992-12-10
AP8600027A0 (en) 1986-02-01
NZ215486A (en) 1988-09-29
IL78158A0 (en) 1986-07-31
DK164392C (da) 1992-11-09
CY1508A (en) 1990-08-03
PT82199B (pt) 1990-11-07
ATA68386A (de) 1989-08-15
CA1238277A (en) 1988-06-21
FI85978B (fi) 1992-03-13
CY1889A (en) 1996-11-22
AU5475886A (en) 1986-09-18
CS385191A3 (en) 1992-05-13
ATE44464T1 (de) 1989-07-15
DE3650130T3 (de) 2003-07-24
IE56503B1 (en) 1991-08-14
DK118086A (da) 1986-09-17
PH24388A (en) 1990-06-13
FI85978C (fi) 1992-06-25
DE3687069T2 (de) 1993-03-25
HK85789A (en) 1989-11-03
FI861069A0 (fi) 1986-03-14
DE3608606A1 (de) 1986-09-18
AP11A (en) 1987-12-22
PT82199A (en) 1986-04-01
DE3650130D1 (de) 1994-12-08
DE3650130T2 (de) 1995-03-16
EP0291633A1 (de) 1988-11-23
JPS63290895A (ja) 1988-11-28
MY102693A (en) 1992-09-30
EP0291633B1 (de) 1992-11-04
EP0196185B1 (de) 1989-07-12
DE196185T1 (de) 1987-04-30
ATE81978T1 (de) 1992-11-15
IE860677L (en) 1986-09-16
AT390000B (de) 1990-02-26
EP0196185A3 (en) 1988-01-13
ATE113603T1 (de) 1994-11-15
DK118086D0 (da) 1986-03-14
AU572019B2 (en) 1988-04-28
GR860712B (en) 1986-07-16
DK164392B (da) 1992-06-22
SG62889G (en) 1990-01-26
JPH0780898B2 (ja) 1995-08-30

Similar Documents

Publication Publication Date Title
IL78158A (en) Pharmaceutical compositions containing 3'-azido-3'-deoxythymidine
NZ226923A (en) 5'-deoxy-5-fluorocytidine derivatives and pharmaceutical compositions
IL88670A0 (en) 2,5-diaryl-tetrahydrofurans and analogs thereof and pharmaceutical compositions containing them
GB2174904B (en) Vasculoprotecting pharmaceutical compositions
IL76405A (en) 1,3-diacyl-2-oxindole derivatives and pharmaceutical compositions containing them
GB8621577D0 (en) Pharmaceutical compositions
IL74865A (en) 4'-amino-9a-aza-9a-homoerythromycin derivatives and pharmaceutical compositions containing them
IL80369A (en) Insecticidal compositions containing n,n'-diacylhydrazine derivatives and certain such new n,n'-diacylhydrazine derivatives
GB2171600B (en) Pharmaceutical compositions
GB8618820D0 (en) Pharmaceutical compositions
EP0197752A3 (en) Pharmaceutical compositions
IL76823A0 (en) 1,2,4-triazolo-carbamates,their preparation and pharmaceutical compositions containing them
GB8515170D0 (en) Pharmaceutical compositions
GB8602602D0 (en) Pharmaceutical compositions
IL79980A0 (en) Pharmaceutical composition containing ypsilon-interferon
PH23343A (en) 8 0( acylaminoergolines and pharmaceutical compositions containing them
IL80733A0 (en) 2,2'-bi-1h-imidazoles and pharmaceutical compositions containing same
SG92592G (en) Pharmaceutical compositions containing azanaphthalenes
GB2182561B (en) Pharmaceutical compositions
GB8523531D0 (en) Pharmaceutical compositions
GB8522327D0 (en) Pharmaceutical compositions
IL85095A0 (en) Pharmaceutical compositions containing 3'-azido-3'-deoxythymidine derivatives,certain such novel compounds and their preparation
IL85095A (en) Pharmaceutical compositions containing 3'-azido-3'-deoxythymidine derivatives,certain such novel compounds and their preparation
AU574620B1 (en) Use of 3'-azido-3'-deoxythymidine
NZ218085A (en) 5-heterocyclic-2,4-dialkyl-3h-1,2,4-triazole-3-thiones and pharmaceutical compositions